Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges
Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges
About this item
Full title
Author / Creator
Ni, Gaoyang , Hu, Zhenbiao , Wang, Ziteng , Zhang, Min , Liu, Xingyu , Yang, Guihong , Yan, Zhaowei and Zhang, Yang
Publisher
United States: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
United States: Hindawi
Subjects
More information
Scope and Contents
Contents
Overcoming blood-brain barrier (BBB) to improve brain bioavailability of therapeutic drug remains an ongoing concern. Prodrug is one of the most reliable approaches for delivering agents with low-level BBB permeability into the brain. The well-known antioxidant capacities of cysteine (Cys) and its vital role in glutathione (GSH) synthesis indicate...
Alternative Titles
Full title
Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8894025
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8894025
Other Identifiers
ISSN
1942-0900
E-ISSN
1942-0994
DOI
10.1155/2022/4834117
